GlassScriptPhysician profile
Allie Boyd Seaton
NPI 1427696582
$10,153.47
in general payments reported to CMS, 2019-2025
38 companies · $3,503 in 2025
The $3,503 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.02 · 2022: $1,542 · 2023: $1,986 · 2024: $3,110 · 2025: $3,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,598.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,851.09 | 2021-2025 | |
| Pfizer INC. | $1,023.28 | 2023-2025 | |
| Ucb, INC. | $859.00 | 2022-2025 | Rystiggo, Nayzilam, Briviact |
| Biogen, INC. | $770.90 | 2023-2025 | Vumerity, Skyclarys, Tysabri |
| Sk Life Science, INC. | $597.14 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $557.80 | 2022-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $542.05 | 2022-2025 | |
| Argenx US, INC. | $396.08 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $360.09 | 2022-2025 | Vyepti, Rexulti |
| Celgene Corporation | $353.07 | 2022-2025 | Zeposia |
| Amneal Pharmaceuticals LLC | $341.38 | 2022-2025 | Rytary, Crexont, Ongentys |
| Teva Pharmaceuticals USA, INC. | $338.70 | 2022-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Eisai INC. | $309.82 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $304.07 | 2023-2025 | Rexulti, Nuedexta |
| Neurocrine Biosciences, INC. | $188.74 | 2022-2025 | Ingrezza, Ongentys |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allie Seaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.